- Open enrollment provides people with Medicare an opportunity to review options, make changes to coverage.
- Evaluating network, extra benefits can help individuals make important plan decisions.
- Astiva Health provides a wide range of valuable extra benefits, leading the industry with its generous grocery allowance and rebate programs, along with transportation services, fitness programs, vision and hearing care, and more.
As Medicare open enrollment approaches, eligible individuals have the chance to review their healthcare options and make important decisions about their coverage. Astiva Health, a leading Medicare Advantage Prescription Drug (“MAPD”) health plan, stands out with its extensive network in Southern California and a broad array of benefits tailored to meet the unique needs of its members. Known for its industry-leading rebates and grocery benefits, Astiva Health is committed to offering a comprehensive solution that not only meets but exceeds the needs of its diverse member population.
Medicare open enrollment for 2024–2025 begins on Oct. 15, 2024, and closes on Dec. 7, 2024, as noted in a recent Medicare Advocates article (https://ibn.fm/eNHOB). During this time, Medicare beneficiaries can make changes to their coverage, including switching between plans, adding or dropping…
NOTE TO INVESTORS: The latest news and updates relating to Astiva are available in the company’s newsroom at https://ibn.fm/Astiva
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
